LECHAUNCY WOODARD to Guideline Adherence
This is a "connection" page, showing publications LECHAUNCY WOODARD has written about Guideline Adherence.
Connection Strength
0.870
-
Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial. JAMA. 2013 Sep 11; 310(10):1042-50.
Score: 0.361
-
Sociodemographic and Health Belief Model Factors Associated with Nonadherence to COVID-19 Mitigation Strategies in the United States. Ann Behav Med. 2021 06 28; 55(7):677-685.
Score: 0.155
-
Calculations of Financial Incentives for Providers in a Pay-for-Performance Program: Manual Review Versus Data From Structured Fields in Electronic Health Records. Med Care. 2015 Oct; 53(10):901-7.
Score: 0.104
-
Financial incentives to control hypertension in patients--reply. JAMA. 2014 Jan 15; 311(3):303-4.
Score: 0.093
-
Design, rationale, and baseline characteristics of a cluster randomized controlled trial of pay for performance for hypertension treatment: study protocol. Implement Sci. 2011 Oct 03; 6:114.
Score: 0.079
-
Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database. Clin Cardiol. 2016 Apr; 39(4):185-91.
Score: 0.027
-
Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011 Sep; 124(9):876-80.e2.
Score: 0.020
-
Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines. Am Heart J. 2011 Jun; 161(6):1140-6.
Score: 0.019
-
Use of smoking cessation interventions and aspirin for secondary prevention: are there racial disparities? Am J Med Qual. 2004 Jul-Aug; 19(4):166-71.
Score: 0.012